Cencora (COR) Competitors

McKesson (NYSE:MCK) and Cencora (NYSE:COR) are both large-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, earnings, community ranking, profitability, dividends, analyst recommendations, institutional ownership and media sentiment.

Is MCK or COR a better dividend stock?

McKesson pays an annual dividend of $2.84 per share and has a dividend yield of 0.4%. Cencora pays an annual dividend of $2.20 per share and has a dividend yield of 0.8%. McKesson pays out 13.0% of its earnings in the form of a dividend. Cencora pays out 31.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. McKesson has raised its dividend for 17 consecutive years and Cencora has raised its dividend for 15 consecutive years.

Does the MarketBeat Community favor MCK or COR?

McKesson received 228 more outperform votes than Cencora when rated by MarketBeat users. Likewise, 74.20% of users gave McKesson an outperform vote while only 65.24% of users gave Cencora an outperform vote.

Company	Underperform	Outperform
McKesson	Outperform Votes 975 74.20%	Underperform Votes 339 25.80%
Cencora	Outperform Votes 747 65.24%	Underperform Votes 398 34.76%

Does the media prefer MCK or COR?

In the previous week, McKesson had 28 more articles in the media than Cencora. MarketBeat recorded 59 mentions for McKesson and 31 mentions for Cencora. Cencora's average media sentiment score of 1.42 beat McKesson's score of 1.39 indicating that Cencora is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
McKesson	47 Very Positive mention(s)	4 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cencora	25 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts rate MCK or COR?

McKesson currently has a consensus price target of $668.50, suggesting a potential downside of 3.46%. Cencora has a consensus price target of $284.20, suggesting a potential downside of 0.07%. Given Cencora's higher possible upside, analysts clearly believe Cencora is more favorable than McKesson.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
McKesson	0 Sell rating(s)	3 Hold rating(s)	12 Buy rating(s)	1 Strong Buy rating(s)	2.88
Cencora	0 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.80

Which has more risk & volatility, MCK or COR?

McKesson has a beta of 0.49, meaning that its stock price is 51% less volatile than the S&P 500. Comparatively, Cencora has a beta of 0.55, meaning that its stock price is 45% less volatile than the S&P 500.

Do institutionals and insiders hold more shares of MCK or COR?

85.1% of McKesson shares are held by institutional investors. Comparatively, 97.5% of Cencora shares are held by institutional investors. 0.1% of McKesson shares are held by insiders. Comparatively, 10.8% of Cencora shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Is MCK or COR more profitable?

McKesson has a net margin of 0.82% compared to Cencora's net margin of 0.46%. Cencora's return on equity of 328.62% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
McKesson	0.82%	-181.26%	5.34%
Cencora	0.46%	328.62%	4.23%

Which has better earnings & valuation, MCK or COR?

McKesson has higher revenue and earnings than Cencora. McKesson is trading at a lower price-to-earnings ratio than Cencora, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
McKesson	$344.58B	0.25	$3.00B	$21.84	31.70
Cencora	$638.56M	86.37	$1.51B	$7.03	40.46

Summary

McKesson beats Cencora on 13 of the 22 factors compared between the two stocks.